Ashwath Jayagopal is Chief Scientific & Dev. Ofc. at Opus Genetics, Inc. (IRD). They have made 3 open-market trades across 2 companies since 2024, most recently 2026-04-23.
CIK 0002008983
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $6K since 2024, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IRD | 509,233 | $2.0M |
| OCUP | 78,500 | $92K |
| Total | $2.1M |
Shares reported on the most recent Form 4, priced at the 2026-04-27 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.